-
C651850-5mgCK2 inhibitor 2 is a potent, selective and orally active inhibitor of CK2 , with an IC 50 of 0.66 nM. CK2 inhibitor 2 shows high selectivity for Clk2 (IC 50 =32.69 nM)/CK2. CK2 inhibitor 2 exhibits favorable antiproliferative and antitumor
-
C656853-1mlCK2 inhibitor 2 is a potent, selective and orally active inhibitor of CK2 , with an IC 50 of 0.66 nM. CK2 inhibitor 2 shows high selectivity for Clk2 (IC 50 =32.69 nM)/CK2. CK2 inhibitor 2 exhibits favorable antiproliferative and antitumor
-
C647440-10mgCKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates ERK1/2 pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs.
-
C647440-1mgCKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates ERK1/2 pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs.
-
C647440-5mgCKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates ERK1/2 pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs.
-
C658930-10mgCMD178 TFA is a lead peptide that consistently reduced the expression of Foxp3 and STAT5 induced by IL-2/s IL-2Rα signaling and inhibits T reg cell development.Appearance:SolidIn Vitro:CMD178 TFA (100 μM) suppresses IL-2-induced STAT5
-
C658930-1mgCMD178 TFA is a lead peptide that consistently reduced the expression of Foxp3 and STAT5 induced by IL-2/s IL-2Rα signaling and inhibits T reg cell development.Appearance:SolidIn Vitro:CMD178 TFA (100 μM) suppresses IL-2-induced STAT5
-
C658930-5mgCMD178 TFA is a lead peptide that consistently reduced the expression of Foxp3 and STAT5 induced by IL-2/s IL-2Rα signaling and inhibits T reg cell development.Appearance:SolidIn Vitro:CMD178 TFA (100 μM) suppresses IL-2-induced STAT5
-
C661623-1mlCMD178 TFA is a lead peptide that consistently reduced the expression of Foxp3 and STAT5 induced by IL-2/s IL-2Rα signaling and inhibits T reg cell development.In Vitro:CMD178 TFA (100 μM) suppresses IL-2-induced STAT5 phosphorylation and inhibits
-
C650316-5mgCoronaridine, an iboga type alkaloid, inhibits the wnt signaling pathway by decreasing β-catenin expression.In VitroCoronaridine (0-40 μM 24 hours) is against non-cancer cells with IC 50 values >40 μM. It agaisnt wnt-dependent cells with IC 50
-
C648628-10mgCorylifol A inhibits IL-6-induced STAT3 activation and phosphorylation, with an IC 50 of 0.81 μM.In VitroCorylifol A shows an inhibitory effect on IL-6-induced STAT3 promoter activity in Hep3B cells with IC 50 value of 0.81±0.15 μM, also inhibits
-
C648628-1mgCorylifol A inhibits IL-6-induced STAT3 activation and phosphorylation, with an IC 50 of 0.81 μM.In VitroCorylifol A shows an inhibitory effect on IL-6-induced STAT3 promoter activity in Hep3B cells with IC 50 value of 0.81±0.15 μM, also inhibits